Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report

Diabetes is a rare, but potentially life‐threatening, adverse event of immune checkpoint inhibitors that requires prompt recognition and treatment. It usually occurs in the first 3 months of treatment and is typically related to programmed cell death‐1 antibodies, alone or in combined therapy. It ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Boswell, Laura, Casals, Gregori, Blanco, Jesús, Jiménez, Amanda, Aya, Francisco, de Hollanda, Ana, Halperin, Irene, Arance, Ana M, Mora, Mireia, Hanzu, Felicia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668074/
https://www.ncbi.nlm.nih.gov/pubmed/34048145
http://dx.doi.org/10.1111/jdi.13604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668074/
https://www.ncbi.nlm.nih.gov/pubmed/34048145
http://dx.doi.org/10.1111/jdi.13604

Ejemplares similares